Furthermore, the competitive GLO1 inhibitor ethyl pyruvate (EP) showed specific antitumor activity in leukemia cell lines, mainly by depleting cancer cell ATP reserves without impairing normal cell function (155). Here, GLO1 is linked to cancer.